CLINICAL_TRIALS
trial_result
· 2019-10-10
Clinical Trial Update: A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis [Phase 4]
Summary
Phase 4 trial update of Crisaborole Ointment 2% in toddlers with mild to moderate atopic dermatitis; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2019-10-10